Code | 2542A | ||||||||||
MA number | EU/1/12/786/003 | ||||||||||
Product Form: | con inf 10x5 ml/4 mg (liek.inj.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Mylan Pharmaceuticals Limited, Ireland | ||||||||||
Therapeutic Class: | 87 - VARIA I | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Parenteral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 23.08.2012 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 17.09.2020 |